The options have a 30-cent strike price and expire 1 May 2020.
() non-executive director Brendan de Kauwe has purchased 2.5 million unlisted options for $107,791.
The options have a 30-cent exercise price, well above the last traded price of 19 cents and expire 1 May 2020.
For these options to have value, the share price must be above 30 cents before this date.
Earlier this week, G Medical released its prospectus detailing a dual-listing on the NASDAQ Capital Market.
The company proposes to raise a minimum of US$17 million through the offer of American Depositary Shares (ADS).
The executives of the company will commence a US investor roadshow on 3 June 2019, after the mandatory exposure period concludes.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...
FOR OUR FULL DISCLAIMER CLICK HERE